×
Glucose Health Net Profit Margin 2014-2019 | GLUC
Prices
Financials
Revenue & Profit
Assets & Liabilities
Margins
Price Ratios
Other Ratios
Other Metrics
Profit Margins
Gross Margin
Operating Margin
EBITDA Margin
Pre-Tax Margin
Net Margin
Glucose Health net profit margin from 2014 to 2019. Net profit margin can be defined as net Income as a portion of total sales revenue.
View More
Glucose Health Net Profit Margin 2014-2019 | GLUC
Prices
Financials
Revenue & Profit
Assets & Liabilities
Margins
Price Ratios
Other Ratios
Other Metrics
Profit Margins
Gross Margin
Operating Margin
EBITDA Margin
Pre-Tax Margin
Net Margin
Glucose Health net profit margin from 2014 to 2019. Net profit margin can be defined as net Income as a portion of total sales revenue.
Related Stocks
Company Name
Market
Cap
Abbott Laboratories (ABT)
$206.3B
Stryker (SYK)
$148B
Boston Scientific (BSX)
$133.7B
EssilorLuxottica (ESLOY)
$111.2B
Medtronic (MDT)
$110.6B
Haleon (HLN)
$44B
Lonza Group Ag (LZAGY)
$42.2B
GE HealthCare Technologies (GEHC)
$37.9B
ResMed (RMD)
$36.6B
Terumo (TRUMY)
$30.3B
Koninklijke Philips (PHG)
$25.5B
Zimmer Biomet Holdings (ZBH)
$22.3B
Insulet (PODD)
$18.7B
Baxter (BAX)
$17B
Smith & Nephew SNATS (SNN)
$11.2B
BellRing Brands (BRBR)
$9.9B
Bio-Rad Laboratories (BIO)
$9.5B
Demant (WILYY)
$8.3B
Lantheus Holdings (LNTH)
$6.3B
TG Therapeutics (TGTX)
$5.4B
Haemonetics (HAE)
$4.4B
Prestige Consumer Healthcare (PBH)
$4.2B
Perrigo (PRGO)
$3.9B
ICU Medical (ICUI)
$3.9B
Envista Holdings (NVST)
$3.8B
Agios Pharmaceuticals (AGIO)
$3.3B
Neogen (NEOG)
$3.1B
Shandong Weigao Medical Polymer (SHWGF)
$3B
GN Store Nord (GNNDY)
$2.9B
QuidelOrtho (QDEL)
$2.8B